- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | Earnings call: LENSAR sees robust growth with ALLY system adoption | 3 | Investing.com | ||
| 09.05. | LENSAR, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.05. | LENSAR GAAP EPS of -$0.19 beats by $0.09, revenue of $10.6M beats by $0.05M | 1 | Seeking Alpha | ||
| 09.05. | LENSAR Reports First Quarter 2024 Results and Provides Business Update | 161 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of... ► Artikel lesen | |
| 08.05. | LENSAR, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.03. | Lake Street bullish on LENSAR stock, cites market growth potential | 3 | Investing.com | ||
| 05.03. | LENSAR, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 05.03. | LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 04.03. | LENSAR, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 04.03. | LENSAR Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 04.03. | LENSAR GAAP EPS of -$0.35, revenue of $12.1M | 1 | Seeking Alpha | ||
| 04.03. | LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update | 563 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of... ► Artikel lesen | |
| 01.03. | LENSAR Q4 2023 Earnings Preview | 2 | Seeking Alpha | ||
| 26.02. | LENSAR, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.02. | LENSAR, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| 09.11.23 | LENSAR Reports Third Quarter 2023 Results and Provides Business Update | 217 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of... ► Artikel lesen | |
| 09.08.23 | LENSAR Reports Second Quarter 2023 Results and Provides Business Update | 262 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen |
Das Unternehmen LENSAR INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,070 (+1,30 %) liegt der Kurs bei 5,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LENSAR INC finden Sie auf Wallstreet Online.
